Tech Company Financing Transactions

Ventus Therapeutics Funding Round

RA Capital, Alexandria Venture Investments and BVF Partners participated in a $100 million Series B funding round for Ventus Therapeutics. The financing round closed on 4/9/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

100 Beaver St. 202
Waltham, MA 02453
USA

Phone

(514) 397-9517

Website

www.ventustx.com

Email Address

[email protected]

Overview

At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. Guided by a patient-centric ethos, our aim is to rapidly advance multiple drug candidates. Our emerging pipeline focuses on the inflammasome and nucleic acid sensing pathways.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Hao Wu

        

Chief Executive Officer

Marcelo Bigal

        

Chief Financial Officer

Zack McNealy

        

Founder

Richard Flavell

        

Founder

Judy Lieberman

        

Founder

Thomas Tuschl

        

Vice President

Michael Turner

        

VP - Bus. Development

Daniel Koerwer

        

VP - R & D

Michael Crackower

        

Browse more venture capital transactions:

Prev: 4/9/2021: Fuel50 venture capital transaction
Next: 4/9/2021: Canvas Medical venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary